INDO-GLOBAL ENT. | INDRAPRASTHA MEDICAL | INDO-GLOBAL ENT./ INDRAPRASTHA MEDICAL |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -31.9 | 21.3 | - | View Chart |
P/BV | x | 1.4 | 6.3 | 22.8% | View Chart |
Dividend Yield | % | 0.0 | 1.1 | - |
INDO-GLOBAL ENT. INDRAPRASTHA MEDICAL |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
INDO-GLOBAL ENT. Mar-20 |
INDRAPRASTHA MEDICAL Mar-23 |
INDO-GLOBAL ENT./ INDRAPRASTHA MEDICAL |
5-Yr Chart Click to enlarge
|
||
High | Rs | 20 | 94 | 21.7% | |
Low | Rs | 20 | 52 | 39.2% | |
Sales per share (Unadj.) | Rs | 0 | 119.9 | 0.0% | |
Earnings per share (Unadj.) | Rs | -0.7 | 9.4 | -7.0% | |
Cash flow per share (Unadj.) | Rs | -0.7 | 13.7 | -4.8% | |
Dividends per share (Unadj.) | Rs | 0 | 3.00 | 0.0% | |
Avg Dividend yield | % | 0 | 4.1 | 0.0% | |
Book value per share (Unadj.) | Rs | 11.1 | 41.4 | 26.8% | |
Shares outstanding (eoy) | m | 6.37 | 91.67 | 6.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0 | 0.6 | - | |
Avg P/E ratio | x | -31.1 | 7.8 | -400.5% | |
P/CF ratio (eoy) | x | -31.1 | 5.3 | -583.1% | |
Price / Book Value ratio | x | 1.8 | 1.8 | 104.2% | |
Dividend payout | % | 0 | 31.9 | -0.0% | |
Avg Mkt Cap | Rs m | 130 | 6,694 | 1.9% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1 | 2,467 | 0.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 0 | 10,987 | 0.0% | |
Other income | Rs m | 0 | 100 | 0.0% | |
Total revenues | Rs m | 0 | 11,087 | 0.0% | |
Gross profit | Rs m | -1 | 1,507 | -0.1% | |
Depreciation | Rs m | 0 | 393 | 0.0% | |
Interest | Rs m | 1 | 43 | 1.6% | |
Profit before tax | Rs m | -2 | 1,172 | -0.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 2 | 310 | 0.7% | |
Profit after tax | Rs m | -4 | 862 | -0.5% | |
Gross profit margin | % | 0 | 13.7 | - | |
Effective tax rate | % | -93.4 | 26.5 | -352.8% | |
Net profit margin | % | 0 | 7.8 | - |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 0 | 2,231 | 0.0% | |
Current liabilities | Rs m | 7 | 1,296 | 0.5% | |
Net working cap to sales | % | 0 | 8.5 | - | |
Current ratio | x | 0 | 1.7 | 0.3% | |
Inventory Days | Days | 0 | 18 | - | |
Debtors Days | Days | 0 | 2 | - | |
Net fixed assets | Rs m | 80 | 3,321 | 2.4% | |
Share capital | Rs m | 64 | 917 | 6.9% | |
"Free" reserves | Rs m | 7 | 2,878 | 0.2% | |
Net worth | Rs m | 71 | 3,795 | 1.9% | |
Long term debt | Rs m | 2 | 0 | - | |
Total assets | Rs m | 80 | 5,551 | 1.4% | |
Interest coverage | x | -2.1 | 28.4 | -7.5% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0 | 2.0 | 0.0% | |
Return on assets | % | -4.4 | 16.3 | -26.7% | |
Return on equity | % | -5.9 | 22.7 | -26.0% | |
Return on capital | % | -2.0 | 32.0 | -6.3% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 1,905 | 0.0% | |
Fx outflow | Rs m | 0 | 360 | 0.0% | |
Net fx | Rs m | 0 | 1,545 | 0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -1 | 1,445 | -0.1% | |
From Investments | Rs m | NA | -1,079 | -0.0% | |
From Financial Activity | Rs m | 1 | -260 | -0.5% | |
Net Cashflow | Rs m | 0 | 105 | 0.0% |
Indian Promoters | % | 2.8 | 49.4 | 5.7% | |
Foreign collaborators | % | 0.0 | 1.6 | - | |
Indian inst/Mut Fund | % | 0.0 | 6.0 | - | |
FIIs | % | 0.0 | 1.1 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 97.2 | 49.0 | 198.3% | |
Shareholders | 543 | 54,158 | 1.0% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare INDO-GLOBAL ENT. With: APOLLO HOSPITALS DR. LAL PATHLABS METROPOLIS HEALTHCARE KIMS NARAYANA HRUDAYALAYA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | INDO-GLOBAL ENT. | INDRAPRASTHA MEDICAL |
---|---|---|
1-Day | -4.76% | -1.11% |
1-Month | 6.24% | 53.80% |
1-Year | -13.28% | 212.41% |
3-Year CAGR | -7.78% | 63.19% |
5-Year CAGR | -4.74% | 46.74% |
* Compound Annual Growth Rate
Here are more details on the INDO-GLOBAL ENT. share price and the INDRAPRASTHA MEDICAL share price.
Moving on to shareholding structures...
The promoters of INDO-GLOBAL ENT. hold a 2.8% stake in the company. In case of INDRAPRASTHA MEDICAL the stake stands at 51.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of INDO-GLOBAL ENT. and the shareholding pattern of INDRAPRASTHA MEDICAL.
Finally, a word on dividends...
In the most recent financial year, INDO-GLOBAL ENT. paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
INDRAPRASTHA MEDICAL paid Rs 3.0, and its dividend payout ratio stood at 31.9%.
You may visit here to review the dividend history of INDO-GLOBAL ENT., and the dividend history of INDRAPRASTHA MEDICAL.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.